Hoyer S - Search Results

1

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.

Harrer DC, Simon B, Fujii SI, Shimizu K, Uslu U, Schuler G, Gerer KF, Hoyer S, Dörrie J, Schaft N. Harrer DC, et al. Among authors: hoyer s. BMC Cancer. 2017 Aug 17;17(1):551. doi: 10.1186/s12885-017-3539-3. BMC Cancer. 2017. PMID: 28818060 Free PMC article.

2

Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells.

Hoyer S, Gerer KF, Pfeiffer IA, Prommersberger S, Höfflin S, Jaitly T, Beltrame L, Cavalieri D, Schuler G, Vera J, Schaft N, Dörrie J. Hoyer S, et al. J Immunol Res. 2015;2015:952184. doi: 10.1155/2015/952184. Epub 2015 Dec 28. J Immunol Res. 2015. PMID: 26824052 Free PMC article.

3

Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.

Gerer KF, Hoyer S, Dörrie J, Schaft N. Gerer KF, et al. Among authors: hoyer s. Methods Mol Biol. 2017;1499:165-178. doi: 10.1007/978-1-4939-6481-9_10. Methods Mol Biol. 2017. PMID: 27987149

4

A fast and robust method to clone and functionally validate T-cell receptors.

Birkholz K, Hofmann C, Hoyer S, Schulz B, Harrer T, Kämpgen E, Schuler G, Dörrie J, Schaft N. Birkholz K, et al. Among authors: hoyer s. J Immunol Methods. 2009 Jul 31;346(1-2):45-54. doi: 10.1016/j.jim.2009.05.001. Epub 2009 May 7. J Immunol Methods. 2009. PMID: 19427315

5

Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.

Pfeiffer IA, Hoyer S, Gerer KF, Voll RE, Knippertz I, Gückel E, Schuler G, Schaft N, Dörrie J. Pfeiffer IA, et al. Among authors: hoyer s. Eur J Immunol. 2014 Nov;44(11):3413-28. doi: 10.1002/eji.201344417. Epub 2014 Sep 16. Eur J Immunol. 2014. PMID: 25100611 Free article.

6

Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.

Hoyer S, Prommersberger S, Pfeiffer IA, Schuler-Thurner B, Schuler G, Dörrie J, Schaft N. Hoyer S, et al. Eur J Immunol. 2014 Dec;44(12):3543-59. doi: 10.1002/eji.201444477. Epub 2014 Oct 27. Eur J Immunol. 2014. PMID: 25211552 Free article. Clinical Trial.

7

Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.

Gerer KF, Erdmann M, Hadrup SR, Lyngaa R, Martin LM, Voll RE, Schuler-Thurner B, Schuler G, Schaft N, Hoyer S, Dörrie J. Gerer KF, et al. Among authors: hoyer s. Ther Adv Med Oncol. 2017 Jul;9(7):451-464. doi: 10.1177/1758834017712630. Epub 2017 Jun 13. Ther Adv Med Oncol. 2017. PMID: 28717398 Free PMC article.

8

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy.

Dörrie J, Babalija L, Hoyer S, Gerer KF, Schuler G, Heinzerling L, Schaft N. Dörrie J, et al. Among authors: hoyer s. Int J Mol Sci. 2018 Jan 18;19(1):289. doi: 10.3390/ijms19010289. Int J Mol Sci. 2018. PMID: 29346301 Free PMC article.

9

Targeted label-free quantification of interleukin-8 in PMA-activated U937 cell secretome by nanoLC-ESI-MS/MS-sSRM.

Emirbayer PE, Gerer KF, Hoyer S, Pischetsrieder M. Emirbayer PE, et al. Among authors: hoyer s. Proteomics. 2017 May;17(9). doi: 10.1002/pmic.201600455. Proteomics. 2017. PMID: 28256805

10

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation.

Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J. Hoyer S, et al. Int J Mol Sci. 2021 Nov 4;22(21):11951. doi: 10.3390/ijms222111951. Int J Mol Sci. 2021. PMID: 34769379 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page